Budesonide Inhalation Suspension
Closed Solicitation Posted
- Solicitation number
- Solicitation_SPE2D224R0005
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is seeking proposals for a national contract to procure budesonide inhalation suspension through its Pharmaceutical Prime Vendor programs. The solicitation covers two specific concentrations of the medication: 0.25mg/2ml and 0.5mg/2ml, with an estimated total quantity of 175,665 boxes for each concentration. Offerors must demonstrate ability to provide the specified products and establish distribution agreements with prime vendors. Technical evaluation criteria will focus on product registration, manufacturing facility compliance, labeling requirements, and past performance. The original response deadline was extended to April 25, 2024, at 3:00 PM EDT, with potential contract award anticipated shortly thereafter.
The solicitation is not set aside for any specific business category and is open to pharmaceutical manufacturers meeting the specified requirements. The contract is structured with a one-year base period and four potential option years, not to exceed a total of five years. Contractors must be prepared to fill orders from prime vendors within 45 days of award, with initial orders potentially reaching up to 30% of estimated annual quantities. Delivery expectations include complete order fulfillment within 15 days and mandatory communication of any backorders within 4 days. Contractors will be required to submit quarterly sales reporting and maintain current cGMP (current Good Manufacturing Practice) compliance, with the contracting officer retaining discretion to consider offers from companies with open FDA warning letters. The contract will support distribution through the Defense Logistics Agency and Department of Veterans Affairs Pharmaceutical Prime Vendor programs.
Notice text
7 versions
Update #7 · Latest ·
Amendment 0007 to cancel the solicitation is attached.
Update #6 ·
Amendment 0006 is attached.
Update #5 ·
Amendment 0005 is attached.
Update #4 ·
N/A
Update #3 ·
Amendment 0005 attached.
Update #2 ·
Budesonide Inhalation Suspension solicitation has been extended to May 2, 2024 03:00PM EDT.
Update #1 ·
See attachment.
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| Budesonide Inhalation Suspension | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Epinephrine Injector | Medical Supply Chain | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity